Resultados de búsqueda - Myra Hardy
- Mostrando 1 - 6 Resultados de 6
-
1
-
2
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised t... por Myra Hardy, Josaia Samuela, Mike Kama, Meciusela Tuicakau, Lucia Romani, Margot J Whitfeld, Christopher L King, Gary J Weil, Anneke C Grobler, Leanne J Robinson, John M Kaldor, Andrew C Steer
Publicado 2020-03-01
Artículo -
3
Community control strategies for scabies: A cluster randomised noninferiority trial. por Myra Hardy, Josaia Samuela, Mike Kama, Meciusela Tuicakau, Lucia Romani, Margot J Whitfeld, Christopher L King, Gary J Weil, Tibor Schuster, Anneke C Grobler, Daniel Engelman, Leanne J Robinson, John M Kaldor, Andrew C Steer
Publicado 2021-11-01
Artículo -
4
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach. por Charles W Goss, Katiuscia O'Brian, Christine Dubray, Peter U Fischer, Myra Hardy, Purushothaman Jambulingam, Christopher L King, Moses Laman, Jean Frantz Lemoine, Leanne J Robinson, Josaia Samuela, Swaminathan Subramanian, Taniawati Supali, Gary J Weil, Kenneth B Schechtman
Publicado 2019-07-01
Artículo -
5
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis. por Alison Krentel, Nandha Basker, Madsen Beau de Rochars, Joshua Bogus, Daniel Dilliott, Abdel N Direny, Christine Dubray, Peter U Fischer, Adriani Lomi Ga, Charles W Goss, Myra Hardy, Cade Howard, Purushothaman Jambulingam, Christopher L King, Moses Laman, Jean Frantz Lemoine, Shruti Mallya, Leanne J Robinson, Josaia Samuela, Ken B Schechtman, Andrew C Steer, Taniawati Supali, Livingstone Tavul, Gary J Weil
Publicado 2021-03-01
Artículo -
6
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study. por Gary J Weil, Joshua Bogus, Michael Christian, Christine Dubray, Yenny Djuardi, Peter U Fischer, Charles W Goss, Myra Hardy, Purushothaman Jambulingam, Christopher L King, Vijesh Sridhar Kuttiat, Kaliannagounder Krishnamoorthy, Moses Laman, Jean Frantz Lemoine, Katiuscia K O'Brian, Leanne J Robinson, Josaia Samuela, Kenneth B Schechtman, Anita Sircar, Adinarayanan Srividya, Andrew C Steer, Taniawati Supali, Swaminathan Subramanian, DOLF IDA Safety Study Group
Publicado 2019-06-01
Artículo